과제정보
We thank Dr. Ronan Jambou, the Scientific Director of CERMES, for reading and correcting the manuscript.
참고문헌
- Organisation mondiale de la Sante. Chimioprevention du paludisme saisonnier par administration de sulfadoxine-pyrimethamine et d'amodiaquine aux enfants: guide de terrain. Geneve: Organisation mondiale de la Sante, 2013 [Internet]. Available from: https://apps.who.int/iris/handle/10665/85727 (in French)
- Esu EB, Oringanje C, Meremikwu MM. Intermittent preventive treatment for malaria in infants. Cochrane Database Syst Rev 2021;7(7):CD011525. https://doi.org/10.1002/14651858.CD011525.pub3
- Marie M. Face au paludisme, le Niger generalise la chimioprevention pour les enfants [Internet]; [cited 2023 Apr 23]. Available from: https://www.lemonde.fr/afrique/article/2018/04/19/face-au-paludisme-le-niger-generalise-la-chimioprevention-pour-les-enfants_5287694_3212.html
- Noor AM, Kibuchi E, Mitto B, Coulibaly D, Doumbo OK, et al. Sub-national targeting of seasonal malaria chemoprevention in the sahelian countries of the nouakchott initiative. PLoS One 2015;10(8):e0136919. https://doi.org/10.1371/journal.pone.0136919
- World Health Organization. Intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP): updated WHO policy recommendation [Internet]. World Health Organization; [cited 2023 Apr 23]. Available from: https://apps.who.int/iris/handle/10665/337990
- Marwa KJ, Mushi MF, Konje E, Alele PE, Kidola J, et al. Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania. AIDS Res Treat 2015;2015:103874. https://doi.org/10.1155/2015/103874
- Naidoo I, Roper C. Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria. Trends Parasitol 2013;29(10):505-515. https://doi.org/10.1016/j.pt.2013.08.002
- Grais RF, Laminou IM, Woi-Messe L, Makarimi R, Bouriema SH, et al. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger. Malar J 2018;17(1):98. https://doi.org/10.1186/s12936-018-2242-4
- Triglia T, Menting JG, Wilson C, Cowman AF. Cowman. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodiumfalciparum. Proc Natl Acad Sci U S A 1997;94(25):13944-13949. https://doi.org/10.1073/pnas.94.25.13944
- Lynch C, Pearce R, Pota H, Cox J, Abeku TA, et al. Emergence of a dhfr Mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda. J Infect Dis 2008;197(11):1598-1604. https://doi.org/10.1086/587845
- High Resolution Melting Analysis. HRM Technology [Internet]; [cited 2023 Jun 29]. Available from: http://www.premier-biosoft.com/tech_notes/high_resolution_melting_analysis.html
- Yavo W, Konate A, Mawili-Mboumba DP, Kassi FK, Tshibola Mbuyi ML, et al. Genetic polymorphism of msp1 and msp2 in Plasmodium falciparum isolates from Cote d'Ivoire versus Gabon. J Parasitol Res 2016;2016:e3074803. https://doi.org/10.1155/2016/3074803
- Ibrahim A, Mahamane Moustapha L, Aboubacar M, Halima Z, Ibrahim ML. Etude du polymorphisme genetique des souches de Plasmodium falciparum au Niger. Revue CAMES SANTE 2017;5(1):42-48 (in French). http://publication.lecames.org/index.php/sante/article/view/648/702
- World Health Organization. Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy: genotyping to identify parasite populations: informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29-31 May 2007, Amsterdam, The Netherlands. World Health Organization. Geneva, Swizerland. 2008, pp 1-45. https://apps.who.int/iris/handle/10665/43824
- Ceesay SJ, Koivogui L, Nahum A, Taal MA, Okebe J, et al. Malaria prevalence among young infants in different transmission settings, Africa. Emerg Infect Dis 2015;21(7):1114-1121. https://doi.org/10.3201/eid2107.142036
- Diakite SAS, Traore K, Sanogo K, Clark TG, Campino S, et al. A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali. Malar J 2019;18(1):361. https://doi.org/10.1186/s12936-019-2986-5
- Daniels R, Ndiaye D, Wall M, McKinney J, Sene PD, et al. Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum. Antimicrob Agents Chemother 2012;56(6):2976-2986. https://doi.org/10.1128/AAC.05737-11
- Dinzouna-Boutamba SD, Iroungou BA, Akombi FL, YackaMouele L, Moon Z, et al. Assessment of genetic polymorphisms associated with malaria antifolate resistance among the population of Libreville, Gabon. Malar J 2023;22(2):183. https://doi.org/10.1186/s12936-023-04615-1
- Wurtz N, Fall B, Pascual A, Diawara S, Sow K, et al. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malar J 2012;11(1):197. https://doi.org/10.1186/1475-2875-11-197
- Beshir KB, Muwanguzi J, Nader J, Mansukhani R, Traore A, et al. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study. Lancet Infect Dis 2023;23(3):361-370. https://doi.org/10.1016/S1473-3099(22)00593-X